Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections

Journal of Surgical Research

Volumn 61, Issue 2, 1996, Pages 425-432

  Hamood, Abdul N ^a   Griswold, John A ^a,b   Duhan, Christopher M ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BACTERIAL TOXIN; ELASTASE; EXOENZYME S; PHOSPHOLIPASE C; TOXIN A; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE; TRACHEITIS; URINARY TRACT INFECTION; WOUND INFECTION;

EID: 0029929646     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0140     Document Type: Article

References (29)

1. Pitcher-Wilmott, R. W., Levinsky, R. J., Gordon, I., Turner, M. W., and Matthew, D. S. Pseudomonas and infection, allergy and cystic fibrosis. Arch. Dis. Child. 57: 582, 1982.
2. Bodey, G., Boliovar, R., Fainstein, V., and Jadeja, L. Infections caused by Pseudomonas aeruginosa. Rev. Infect. Dis. 5: 279, 1983.
3. Cash, H. A., Straus, D. C., and Bass, J. A. Pseudomonas aeruginosa exoproducts as pulmonary virulence factors. Can. J. Microbiol. 29: 448, 1983.
4. Woods, D. E., and Iglewski, B. H. Toxins of Pseudomonas aeruginosa: New prospective. Rev. Infect. Dis. 5: S715, 1983.
5. Iglewski, B. H., and Kabat, D. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin. Proc. Natl. Acad. Sci. U.S.A. 2: 2284, 1975.
6. Iglewski, B. H., Sadoff, J. C., Bjorn, M. J., and Maxwell, E. S. Pseudomonas aeruginosa exoenzyme S: An adenosine diphosphate ribosyl transferase distinct from toxin A. Proc. Natl. Acad. Sci. U.S.A. 75: 3211, 1978.
7. Bjorn, M. J., Pavlovskis, O. R., Thompson, M. R., and Iglewski, B. H. Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice. Infect. Immun. 24: 837, 1979.
8. Morihara, K. Production of elastase and proteinase by Pseudomonas aeruginosa. J. Bacteriol. 88: 745, 1964.
9. Scultz, D. R., and Miller, K. D. Elastase of Pseudomonas aeruginosa: Inactivation of complement components and complement derived chemotactic and phagocytic factors. Infect. Immun. 10: 128, 1974.
10. Berk, R. S., Brown, D., Coutinho, I., and Meyers, D. In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa. Infect. Immun. 55: 1728, 1987.
11. Berka, R. M., Gray, G. L., and Vasil, M. L. Studies of phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa. Infect. Immun. 34: 1071, 1981.
12. Cryz, S. J., Pitt, T. L., Furer, E., and Germanier, R. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect. Immun. 44: 508-513, 1984.
13. Snell, K., Holder, I. A., Leppla, S. A., and Saelinger, C. B. Role of exotoxin and protease as possible virulence factors in experimental infection with Pseudomonas aeruginosa. Infect. Immun. 19: 839, 1978.
14. Woods, D. E., To, M., and Sokol, P. A. Pseudomonas aeruginosa exoenzyme S as a pathogenic determinant in respiratory infections. Antibiot. Chemother. 42: 27, 1989.
15. Gomer, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., and Hughes, J. M. CDC definitions for nosocomial infections. Am. J. Infect. Control 16: 128, 1988.
16. Ohman, D. E., Sadoff, J. C., and Iglewski, B. H. Toxin A deficient mutants of Pseudomonas aeruginosa PA103: Isolation and characterization. Infect. Immun. 28: 899, 1980.
17. Schad, P. A., Bever, R. A., Nicas, T. I., Leduc, F., Hanne, L. E., and Iglewski, B. H. Cloning and characterization of elastase genes from Pseudomonas aeruginosa. J. Bacteriol. 169: 2691, 1987.
18. Nicas, T. I., and Iglewski, B. H. Isolation and characterization of transposon induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S. Infect. Immun. 45: 470, 1984.
19. Berka, R. M., and Vasil, M. L. Phospholipase C (heat labile hemolysin) of Pseudomonas aeruginosa: Purification and preliminary characterization. J. Bacteriol. 152: 239, 1982.
20. Miller, J. H. 1972. Experiments in Molecular Genetics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
21. Voller, A., Bidwell, D. Enzyme linked immunosorbent assay manual of Clinical Laboratory Immunology. In N. R. Rose, H. Friedman, and J. L. Fahey (Eds.), Manual of Clinical Laboratory Immunology. Washington: American Society for Microbiology, 1988. Pp. 99.
22. Olson, J. C., Hamood, A. N., Vincent, T., Beachey, E., Iglewski, B. H. Identification of functional epitopes of Pseudomonas aeruginosa exotoxin A using synthetic peptides and subclone products. Mol. Immunol. 27: 981, 1990.
23. SAS GLM. SAS User's Guide release 6.08, SAS Institute, Inc., 1989, Cary, NC.
24. Pollack, M., and Young, L. S. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J. Clin. Invest. 63: 276, 1979.
25. Mahan, M., Slauch, J., and Mekalanos, J. J. Selection of bacterial virulence genes that are specifically induced in host tissues. Since 259: 686, 1993.
26. Woods, D. E., Schaffer, M. S., Rabin, H. R., Campbell, G. D., and Sokol, P. A. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J. Clin. Microbiol. 24: 260, 1986.
27. Woods, D. E., Sokol, P. A., Bryan, L. E., Storey, D. G., Mattingly, S. J., Vogel, H. J., and Ceri, H. In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement. J. Infect. Dis. 163: 143, 1991.
28. Frank, D. W., and Iglewski, B. H. Cloning and sequence analysis of a trans-regulatory locus required for exoenzyme S synthesis in Pseudomonas aeruginosa. J. Bacteriol. 173: 6460, 1991.
29. Sokol, P. A., Luan, M., Storey, D. G., and Thirukumaran, P. Genetic rearrangement associated with in vivo mucoid conversion of Pseudomonas aeruginosa PAO1 is due to insertion element. J. Bacteriol. 176: 553, 1994.